National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No. 8) (No. PB 51 of 2011) (Cth)
National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No.8)
Instrument number PB 51 of 2011
National Health Act 1953
I, FELICITY MCNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 26 July 2011
FELICITY MCNEILL
Acting First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
Part 1 Preliminary
Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2011(No.8).
(2) This Determination may also be cited as PB 51 of 2011.
Commencement
This Determination commences on 1 August 2011.
Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Disopyramide
Omit
Dolasetron
[2] Schedule 1, after item dealing with Everolimus
Omit
Exemestane
[3] Schedule 1, after item dealing with Fenofibrate
Omit
Fentanyl
[4] Schedule 2, after item dealing with Etoposide
Insert
Exemestane
[5] Schedule 2, after item dealing with Felodipine
Insert
Fentanyl
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See
0
0
0